Santa Cruz Biotechnology offers a broad range of Ricin B monoclonal antibodies for advanced research in toxicology and cell biology. Ricin B monoclonal antibodies support various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ricin B is a potent lectin derived from the castor bean plant, known for its ability to bind to cell surface glycoproteins and facilitate the entry of the toxic ricin A chain into cells. Understanding the mechanisms of Ricin B is crucial for developing therapeutic strategies against ricin poisoning and for studying its role in cellular processes. The study of Ricin B provides insights into the broader implications of plant-derived toxins in human health and disease. Researchers worldwide utilize Ricin B monoclonal antibodies to investigate cellular uptake mechanisms and toxin trafficking pathways. Advanced detection methods with Ricin B monoclonal antibodies enable precise tracking of toxin distribution in various cellular compartments. The exceptional specificity of Santa Cruz Biotechnology monoclonal antibodies supports researchers in advancing our understanding of toxin-cell interactions and potential therapeutic interventions.